Literature DB >> 8475298

Preoperative needle localization in the breast: utility of local anesthesia.

H E Reynolds1, V P Jackson, B S Musick.   

Abstract

Eighty-nine consecutive patients undergoing needle localization at two facilities were alternately assigned to "local-anesthesia" (n = 46) and "no-local-anesthesia" (n = 43) groups. Those in the local-anesthesia group received 1-2 mL lidocaine hydrochloride 1% subcutaneously at the expected site of insertion of the localizing needle. All patients were asked to rate the level of pain they experienced from the procedure as a whole by using a 10-cm horizontal visual analog pain scale. Data about patient age, menopausal and menstrual status, average daily caffeine intake, and whether the patients considered mammography to be a painful procedure were collected. Patients who did not receive local anesthesia had a lower mean pain score (2.52) than those who did (3.27, P = .18). Premenopausal patients in the second half of their menstrual cycle at the time of the procedure had a significantly higher pain score than those in the first half (3.54 vs. 1.70, P = .05). Patients who considered mammography a painful procedure reported a higher level of pain than those who did not (3.79 vs 2.38, P = .012). There was no relationship between age, caffeine intake, or menopausal status and pain experienced.

Entities:  

Mesh:

Year:  1993        PMID: 8475298     DOI: 10.1148/radiology.187.2.8475298

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

1.  Presurgical localization of breast abnormalities: an overview and analysis of 202 cases.

Authors:  Mahesh K Shetty
Journal:  Indian J Surg Oncol       Date:  2010-12-30

2.  Caffeine Consumption Influences Lidocaine Action via Pain-Related Voltage-Gated Sodium Channels: An In Vivo Animal Study.

Authors:  Reham Alfaraj; Zainab Alabdulsalam; Zahrah Alfaraj; Hawraa Alsunni; Hussain Alhawaj; Omar Omar; Hatem Abuohashish
Journal:  Pain Res Manag       Date:  2022-01-04       Impact factor: 3.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.